Study on the mechanism of Tanreqing injection combined with antibiotics on respiratory system-related drug-resistant bacteria based on drug resistance sensitization

Medical Experimental Center of China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•? Meet the diagnostic criteria of lower respiratory tract infection (pneumonia, acute exacerbation of chronic obstructive pulmonary disease, bronchiectasis complicated infection) and need antibiotic treatment;
•?Age between 40 and 80 years old (including 40 and 80 years old);
•? Obtain qualified sputum specimens of the lower respiratory tract (sputum smear: =10 squamous epithelial cells in each low-power microscope field, and =25 leukocytes per low-power field), and the sputum bacteria were cultured as drug-resistant Pseudomonas aeruginosa bacteria;
•? In line with the syndrome of phlegm-heat obstructing the lung;
•? Accept the treatment plan voluntarily and sign the informed consent.

•? Pulmonary tuberculosis patients;
•? Non-resistant Pseudomonas aeruginosa infection;
•? Immunodeficiency patients or taking immunosuppressive agents or glucocorticoids within the past 3 months;
•? Patients with severe liver and kidney dysfunction, severe pulmonary heart disease with heart failure or hematopoietic system and other serious primary diseases;
•? Pregnant and lactating patients;
•? Those who are allergic to the study drug or its components;
•? Other doctors think that it is not suitable to participate in this researcher.

发起方

Medical Experimental Center of China Academy of Chinese Medical Sciences